Rozpětí
€156.77
Live · Q4 2026Trhy EU,
Trhy EU,
v jednom kanálu.
Informační vrstva za B2B platformou ViraChem. Aktuální spotové ceny, novinky R&D z otevřených registrů a terénní výzkum pro farmaceutické a biotechnologické laboratoře po celé Evropě — přímo z naší obchodní sítě, aktualizováno každou hodinu.
/ 02 Spotové ceny
Živé ceny a analýza/ 7-day spot · €/g · 24 compounds
Aktualizováno každou hodinuVšechny sloučeniny →
BPC-157 acetate · In Vivo
7d
€/g
€/g
€156/g▼~-5.5%
−30d−20d−10dnyní
Čistota HPLC
≥98%
Grade
In Vivo
GHK-cu acetate · In Vivo
7d
€/g
€/g
€4/g▼~-3.5%
−30d−20d−10dnyní
Rozpětí
€4.39
Čistota HPLC
≥98%
Grade
In Vivo
Mots-c acetate · In Vivo
7d
€/g
€/g
€277/g▼~-4.8%
−30d−20d−10dnyní
Rozpětí
€274.36
Čistota HPLC
≥98%
Grade
In Vivo
CJC 1295 NO DAC acetate · In Vivo
7d
€/g
€/g
€512/g▼~-1.4%
−30d−20d−10dnyní
Rozpětí
€509.52
Čistota HPLC
≥98%
Grade
In Vivo
Sloučenina · chemie
7denní trend
€/g · spot
1d · 7d · 30d
Čistota HPLC
BPCBPC-157 acetate· raw powder
In Vivoacetate
CAS137525-51-0MW1419.5 g/molSůlacetateCID9941957SEQGEPPPGKPADDAGLVInChIHEEWEZGQMLZMFE-RKGINYAYSA-N
€156/g
1d~+2.6%7d▼ ~-5.5%30d~+11.1%
≥98%
GHKGHK-cu acetate· raw powder
In Vivoacetate
CAS89030-95-5MW401.91 g/molSůlacetateCID139035031SEQGly-His-Lys (Cu²⁺)InChILREZPQNYQZAPJC-ACMTZBLWSA-L
€4/g
1d~-0.7%7d▼ ~-3.5%30d~-11.2%
≥98%
MOTMots-c acetate· raw powder
In Vivoacetate
CAS1627580-64-6MW2174.6 g/molSůlacetateCID146675088SEQMRWQEMGYIFYPRKLRInChIWYTHCOXVWRKRAH-LOKRTKBUSA-N
€277/g
1d~-1.3%7d▼ ~-4.8%30d~-2.8%
≥98%
CJCCJC 1295 NO DAC acetate· raw powder
In Vivoacetate
CAS863288-34-0MW3367.9 g/molSůlacetateCID56841945SEQY-(D-A)-D-A-I-F-T-Q-S-Y-R-K-V-L-A-Q-L-S-A-R-K-L-L-Q-D-I-L-S-R-NH2InChIXOZMWINMZMMOBR-HRDSVTNWSA-N
€512/g
1d~+1.6%7d▼ ~-1.4%30d~+14.2%
≥98%
EPIEpithalon acetate· raw powder
Industrialacetate
CAS64082-79-7MW390.35 g/molSůlacetateCID219042SEQAEDGInChIHGHOBRRUMWJWCU-FXQIFTODSA-N
€105/g
1d~+0.5%7d▲ ~+9.3%30d~+3.2%
>90%
THYThymosin alpha 1 acetate· raw powder
In Vivoacetate
CAS62304-98-7MW3108.3 g/molSůlacetateCID16130571SEQSDAAVDTSSEITTKDLKEKKEVVEEAENInChINZVYCXVTEHPMHE-ZSUJOUNUSA-N
€562/g
1d~-2.2%7d▼ ~-5.7%30d~-4.6%
≥98%
THY3Thymulin acetate· raw powder
Industrialacetate
CAS63958-90-7MW858.9 g/molSůlacetateCID71300623SEQXAKSQGGSNInChILIFNDDBLJFPEAN-YTAPOSPOSA-N
€165/g
1d~-0.2%7d▼ ~-4.5%30d~-6.0%
>90%
AMI5-Amino 1MQ chloride· raw powder
In Vivochloride
CAS685079-15-6MW159.21 g/molSůlchlorideCID950107InChIZMJBCEIHNOWCMC-UHFFFAOYSA-O
€2/g
1d~+3.3%7d▼ ~-2.4%30d~-9.1%
≥98%
AODAOD-9604 acetate· raw powder
In Vivoacetate
CAS221231-10-3MW1815.1 g/molSůlacetateCID71300630SEQYLRIVQCRSVEGSCGFInChIGVIYUKXRXPXMQM-BPXGDYAESA-N
€874/g
1d~-1.6%7d▼ ~-5.4%30d~-9.8%
≥98%
DSIDSIP acetate· raw powder
In Vivoacetate
CAS62568-57-4MW848.8 g/molSůlacetateCID68816SEQWAGGDASGEInChIZRZROXNBKJAOKB-GFVHOAGBSA-N
€196/g
1d~+3.7%7d▲ ~+7.9%30d~+10.4%
≥98%
IPAIpamorelin acetate· raw powder
In Vivoacetate
CAS170851-70-4MW711.9 g/molSůlacetateCID9831659SEQXHXFKInChINEHWBYHLYZGBNO-BVEPWEIPSA-N
€243/g
1d~-0.9%7d▼ ~-4.8%30d~+5.3%
≥98%
KPV
KPVKPV acetate· raw powder
In Vivo
€223/g
1d~+0.1%7d▼ ~-1.7%30d~-7.5%
≥98%
KISKisspeptin-10 acetate· raw powder
In Vivoacetate
CAS374675-21-5MW1302.4 g/molSůlacetateCID25240297SEQYNWNSFGLRFInChIRITKWYDZSSQNJI-INXYWQKQSA-N
€285/g
1d~-3.1%7d▼ ~-5.3%30d~-4.3%
≥98%
LLALL-37 acetate· raw powder
In Vivoacetate
CAS154947-66-7MW4493 g/molSůlacetateCID16198951SEQLLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTESInChIPOIUWJQBRNEFGX-XAMSXPGMSA-N
€774/g
1d~+2.8%7d▲ ~+3.7%30d~+0.3%
≥98%
MELMelanotan 2 acetate· raw powder
Industrialacetate
CAS121062-08-6MW1024.18 g/molSůlacetateCID92432SEQXDHFRWKInChIJDKLPDJLXHXHNV-MFVUMRCOSA-N
€162/g
1d~-3.7%7d▲ ~+5.7%30d~+12.6%
>90%
NADNAD+· raw powder
In Vivo
CAS53-84-9MW663.4 g/molCID5892InChIBAWFJGJZGIEFAR-NNYOXOHSSA-N
€1/g
1d~+4.7%7d▲ ~+8.5%30d~+8.5%
≥98%
PEG
PEGPEG-MGF acetate· raw powder
In Vivoacetate
MW4888 g/molSůlacetateSEQYQPPSTNKNTKSQRRKGSTFEERK-NH2
€1,380/g
1d~+1.4%7d▲ ~+11.0%30d~+14.9%
≥98%
PTAPT-141 acetate· raw powder
In Vivoacetate
CAS189691-06-3MW1025.2 g/molSůlacetateCID9941379SEQXDHFRWKInChIFFHBJDQSGDNCIV-MFVUMRCOSA-N
€378/g
1d~0.0%7d▲ ~+6.3%30d~+0.4%
≥98%
RETRetatrutide acetate· raw powder
In Vivoacetate
CAS2381089-83-2MW4731.33 g/molSůlacetateCID171390338SEQY-Aib-QGTFTSDYSI-αMeLeu-LDK-Lys(19-carboxy-nonadecanoyl-γGlu-AEEA)-AQ-Aib-AFIEYLLEGGPSSGAPPPS-NH₂InChIMLOLQJNKXBNWFW-SAGGEDDASA-N
€164/g
1d~-3.6%7d▼ ~-8.2%30d~-12.4%
≥98%
SS3SS-31 acetate· raw powder
In Vivoacetate
CAS736992-21-5MW639.8 g/molSůlacetateCID11764719SEQRXKFInChISFVLTCAESLKEHH-WKAQUBQDSA-N
€329/g
1d~+2.6%7d▲ ~+11.0%30d~+2.0%
≥98%
SELSelank acetate· raw powder
In Vivoacetate
CAS129954-34-3MW751.9 g/molSůlacetateCID11765600SEQTKPRPGPInChIJTDTXGMXNXBGBZ-YVHUGQOKSA-N
€187/g
1d~+1.7%7d▼ ~-0.9%30d~-9.1%
≥98%
SEMSemax acetate· raw powder
In Vivoacetate
CAS80714-61-0MW813.9 g/molSůlacetateCID9811102SEQMEHFPGPInChIAFEHBIGDWIGTEH-AQRCPPRCSA-N
€192/g
1d~+1.4%7d▲ ~+2.9%30d~+9.5%
≥98%
TESTesamorelin acetate· raw powder
In Vivoacetate
CAS218949-48-5MW5136 g/molSůlacetateCID16137828SEQYADAIFTNSYRKVLGQLSARKLLQDIMSRQQGESNQERGARARLInChIQBEPNUQJQWDYKU-BMGKTWPMSA-N
€541/g
1d~+1.4%7d▲ ~+5.8%30d~+3.0%
≥98%
THY4Thymosin beta-4 acetate· raw powder
In Vivoacetate
CAS77591-33-4MW4963 g/molSůlacetateCID45382195SEQSDKPDMAEIEKFDKSKLKKTETQEKNPLPSKETIEQEKQAGESInChIUGPMCIBIHRSCBV-UHFFFAOYSA-N
€571/g
1d~+0.6%7d▲ ~+2.3%30d~-2.1%
≥98%
Prices derive from ViraChem’s active network of trade, converted to EUR at the ECB daily reference rate for each transaction date. Metodika →
24 compounds·€/g·ECB · EUR/USD 1.1188·Updated 07:59 CET·Q4 2026
/ 03 Puls novinek
Puls zpráv a nejnovější výzkum/ otevřené registry · blog
Aktualizováno každou hodinuCelý kanál →
Kanál novinek R&DEUROPE PMC · CT.GOV
13 OCT
PreprintbioRxiv· immunology
Self-reactive human CD8⁺ T cells restricted by HLA-E mediate immunoregulatory and antiviral functions
HLA-E constitutively presents self VL9 peptides on healthy cells, signaling an intact HLA class I pathway and protecting cells from natural killer cell attack. Beyond this canonical role, HLA-E-restricted CD8 T cells …
Walters, L. C.; Guo, X.; Casquero, C.; Urbach, J. M.; Leddy, O.; Cakan, E.; Chan, A. O.; Balivada, P. A.; Wisner, H.; Bryson, B. D.; Whit…
13 OCT
Klinická studieClinicalTrials.gov· PHASE3 · RECRUITING
A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)
The main goals of this study are to learn about the safety of sacituzumab tirumotecan with bevacizumab and if people tolerate it; and if people who take sacituzumab tirumotecan with or without bevacizumab live longer …
Merck Sharp & Dohme LLC
13 OCT
Klinická studieClinicalTrials.gov· PHASE2 · NOT_YET_RECRUITING
Intensive Locoregional Chemoimmunotherapy, Intradermal Autologous Alpha-DC1 Vaccines, and Systemic Pembrolizumab for Advanced-Stage Ovarian Cancer
This trial proposes to evaluate the immunologic and potential clinical effectiveness of intensive locoregional sequential intraperitoneal (IP) cisplatin (IPC) with intravenous (iv) paclitaxel followed by peritoneal in…
Kalinski, Pawel, MD, PhD
13 OCT
Klinická studieClinicalTrials.gov· PHASE2 · RECRUITING
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
This MyeloMATCH Master Screening and Reassessment Protocol (MSRP) evaluates the use of a screening tool and specific laboratory tests to help improve participants' ability to register to clinical trials throughout the…
National Cancer Institute (NCI)
13 OCT
Klinická studieClinicalTrials.gov· PHASE2 · RECRUITING
Antiangiogenic Therapy for Children With Recurrent Medulloblastoma, Ependymoma, ATRT and Rare CNS Tumors
Patients with with recurrent or progressive medulloblastoma, ependymoma, atypical teratoid rhabdoid tumor (ATRT), and CNS tumors of various histologies have a very poor prognosis whether treated with conventional chem…
Medical University of Vienna
13 OCT
Klinická studieClinicalTrials.gov· PHASE2 · NOT_YET_RECRUITING
A Study to Assess The Safety and Tolerability of Pumitamig-Based Therapy Administered Before Surgery in Participants With Early-Stage Non-Small Cell Lung Cancer (ROSETTA Lung-220)
The purpose of this study is to assess the safety, tolerability, and surgical feasibility of preoperative Pumitamig-based therapy and other molecules in resectable, Early-Stage Non-Small Cell Lung Cancer
Bristol-Myers Squibb
Nejnovější výzkumPOZNÁMKY Z PRAXE · ANALÝZA
Analytical Science
Novo Nordisk Study Finds Follow-On Liraglutide Less Physically Stable Than Originator
Clinical Research
Genetic Analysis Argues for Lower GIP While Tirzepatide Agonises the Receptor
Regulatory
Consensus Statements Fill the GLP-1 Evidence Gap Regulators Have Not
Clinical Research
Low-Dose Tirzepatide Matched 5 mg on Weight Loss in a 112-Patient Japanese Cohort
Clinical Research
Semaglutide Withdrawal Trial Asks Whether Tapering Beats Stopping Cold
24 compounds·€/g·ECB · EUR/USD 1.1188·Updated 07:59 CET·Q4 2026
/ 04 Metodika
Celá metodika →Jak data vznikají/ zdroj · převod · aktualizace
M · 01
Data ze skutečných obchodů
Každá spotová cena vychází ze skutečných objednávek procházejících obchodní sítí ViraChem v EU — nikoli z dotazníků ani ze stahování ceníků.
Zdroj →M · 02EUR přepočtené dle ECB
Transakce v jiných měnách než euro se převádějí na eura denním referenčním kurzem ECB k danému dni obchodu. Stejná konvence napříč spotovými cenami.
Přepočet →M · 03Obnova každou hodinu
Spotové ceny, změny trendu a řádky tickeru se obnovují každou hodinu. Každý řádek nese TTL, takže aktuálnost je auditovatelná navazujícími systémy.
Frekvence →24 compounds·€/g·ECB · EUR/USD 1.1188·Updated 07:59 CET·Q4 2026
/ 05 Prozkoumat
Procházet archiv →Kategorie výzkumu/ 3 working lenses
CAT · 01→CAT · 02→CAT · 03→
Analytical Science
Characterisation, impurity profiling, and stability of peptide materials.
1
Články
Clinical Research
Trial design, results, and pipeline movement in peptide therapeutics.
5
Články
Regulatory
EMA, FDA and pharmacopoeial developments affecting peptide drug substance and product.
1
Články
/ 06 Zdroje dat
Europe PMCClinicalTrials.govUSPTObioRxivECB
Otevřené registry · denní obnova/ obchodní platformaPotřebujete nakoupit,
Potřebujete nakoupit,
a nejen číst?
B2B webová platforma — katalog produktů, nástroje RFQ, analytická dokumentace a doprava v rámci EU — je na virachemical.com.
Navštivte virachemical.com/ čím se zabýváme
Hotové formáty, zakázková výroba, plnění a finalizace.
71 specifikací tříd v 11 kategoriích — Pharma, Cosmetic, Food, Analytical, IVD, Cell culture, Industrial a další.
Zobrazit služby/ poptat nabídku
Poptávky a nabídky dle objemových pásem do 1 pracovního dne.
Sdělte nám sloučeninu, množství a formu. Ozveme se s dostupností, dodací lhůtou a dodanou cenou v rámci EU.
Vyžádat nabídku